Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-2-26
pubmed:abstractText
Recent data indicate that ketamine exerts antiinflammatory actions. However, little is known about the signaling mechanisms involved in ketamine-induced immune modulation. In this study, we investigated the effects of ketamine on lipopolysaccharide-induced activation of transcription factors activator protein 1 (AP-1) and nuclear factor-kappaB (NF-kappaB) in human leukocyte-like cell lines and in human blood neutrophils.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD11b, http://linkedlifedata.com/resource/pubmed/chemical/FCGR3B protein, human, http://linkedlifedata.com/resource/pubmed/chemical/GPI-Linked Proteins, http://linkedlifedata.com/resource/pubmed/chemical/IL8 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/ITGAM protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-8, http://linkedlifedata.com/resource/pubmed/chemical/Ketamine, http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, IgG, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, N-Methyl-D-Aspartate, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, mu, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factor AP-1, http://linkedlifedata.com/resource/pubmed/chemical/lipopolysaccharide, E. coli 026-B6
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1526-7598
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
110
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
934-41
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:20185670-Adult, pubmed-meshheading:20185670-Anti-Inflammatory Agents, pubmed-meshheading:20185670-Antigens, CD11b, pubmed-meshheading:20185670-Dose-Response Relationship, Drug, pubmed-meshheading:20185670-Down-Regulation, pubmed-meshheading:20185670-Electrophoretic Mobility Shift Assay, pubmed-meshheading:20185670-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:20185670-Flow Cytometry, pubmed-meshheading:20185670-GPI-Linked Proteins, pubmed-meshheading:20185670-HL-60 Cells, pubmed-meshheading:20185670-Humans, pubmed-meshheading:20185670-Interleukin-8, pubmed-meshheading:20185670-Ketamine, pubmed-meshheading:20185670-Leukocytes, pubmed-meshheading:20185670-Lipopolysaccharides, pubmed-meshheading:20185670-Male, pubmed-meshheading:20185670-NF-kappa B, pubmed-meshheading:20185670-Neutrophils, pubmed-meshheading:20185670-Receptors, IgG, pubmed-meshheading:20185670-Receptors, N-Methyl-D-Aspartate, pubmed-meshheading:20185670-Receptors, Opioid, mu, pubmed-meshheading:20185670-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:20185670-Signal Transduction, pubmed-meshheading:20185670-Transcription Factor AP-1, pubmed-meshheading:20185670-U937 Cells, pubmed-meshheading:20185670-Young Adult
pubmed:year
2010
pubmed:articleTitle
Ketamine inhibits transcription factors activator protein 1 and nuclear factor-kappaB, interleukin-8 production, as well as CD11b and CD16 expression: studies in human leukocytes and leukocytic cell lines.
pubmed:affiliation
School of Clinical Science, University of Liverpool, The Duncan Building, Daulby St., Liverpool L69 3GA, UK. i.welters@chiru.med.uni-giessen.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't